推荐产品
一般描述
Arsenic(III) oxide is a volumetric standard produced under rigorous conditions and measured with the highest possible precision. Its content determination and homogeneity assessment are carried out using volumetric redox titration as the primary analysis method.
应用
The reference material is to be used as a reductometric standard for titer determinations in redox titrations.
特点和优势
- Available as a solid in a secure glass bottle to ensure its stability for the entire shelf life until opened.
- Traceable to NIST standard reference material
- Offers accurate titer determinations
- Accompanied by a certificate of analysis (CoA)
分析说明
精确浓度、有效期以及认证的详细信息请见每个包装内的证书和认证报告。标签上标明含量和有效期。
警示用语：
Danger
危险分类
Acute Tox. 2 Oral - Aquatic Acute 1 - Aquatic Chronic 1 - Carc. 1A - Eye Dam. 1 - Skin Corr. 1B - STOT RE 1
靶器官
Respiratory system,Cardio-vascular system,Gastrointestinal tract
储存分类代码
6.1A - Combustible acute toxic Cat. 1 and 2 / very toxic hazardous materials
WGK
WGK 3
闪点(°F)
Not applicable
闪点(°C)
Not applicable
个人防护装备
Eyeshields, Faceshields, Gloves, type P3 (EN 143) respirator cartridges
法规信息
监管及禁止进口产品
Michael Ash, Irene Ash
Handbook of Preservatives, 281 -281 (2004)
Arsenic?glutathione complexes?their stability in solution and during separation by different HPLC modes.
Raab, Andrea, et al.
Journal of Analytical Atomic Spectrometry, 19.1, 183-190 (2004)
Cui Li et al.
Toxicology letters, 219(3), 223-230 (2013-04-02)
Arsenic trioxide (As2O3; ATO) is clinically effective in treating acute promyelocytic leukemia (APL); however, it frequently causes cardiotoxic effects. This study was designed to investigate whether ATO could induce apoptosis of cardiac fibroblasts (CFs) that play very important roles in
Ling-Huei Yih et al.
Toxicology and applied pharmacology, 267(3), 228-237 (2013-01-29)
Accumulated evidence has revealed a tight link between arsenic trioxide (ATO)-induced apoptosis and mitotic arrest in cancer cells. AKT, a serine/threonine kinase frequently over-activated in diverse tumors, plays critical roles in stimulating cell cycle progression, abrogating cell cycle checkpoints, suppressing
Masamitsu Yanada et al.
Blood, 121(16), 3095-3102 (2013-02-16)
The optimal treatments for relapsed acute promyelocytic leukemia (APL) remain equivocal. We conducted a phase 2 study to evaluate the efficacy and feasibility of a sequential treatment consisting of induction and consolidation with arsenic trioxide (ATO), peripheral blood stem cell
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门